PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35401395-0	2022	KCNQ2-Related Neonatal Epilepsy Treated With Vitamin B6: A Report of Two Cases and Literature Review.	Vitamin B 6	45-55	potassium voltage-gated channel subfamily Q member 2	Homo sapiens	0-5	
26446091-0	2016	Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6.	Vitamin B 6	49-59	potassium voltage-gated channel subfamily Q member 2	Homo sapiens	18-23	
26446091-2	2016	Whole-exome sequencing was used to identify a de novo mutation (c.629G>A; p.Arg210His) in KCNQ2 in a 7-year-old patient whose neonatal seizures showed a response to pyridoxine and who had a high plasma to CSF pyridoxal 5"-phosphate ratio, usually indicative of an inborn error of vitamin B6 metabolism.	Vitamin B 6	283-293	potassium voltage-gated channel subfamily Q member 2	Homo sapiens	93-98	
26446091-4	2016	A review of the literature was performed to assess the effectiveness of vitamin B6 treatment in patients with a KCNQ2 channelopathy.	Vitamin B 6	72-82	potassium voltage-gated channel subfamily Q member 2	Homo sapiens	112-117	
28420012-3	2017	Recently, there are indications that some patients with KCNQ2 NEE show seizure response to vitamin B6 (VB6) therapy.	Vitamin B 6	91-101	potassium voltage-gated channel subfamily Q member 2	Homo sapiens	56-61